Free Trial

Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership

+0.22 (+1.92%)
(As of 03:59 PM ET)

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
Get ENTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ENTA Insider Buying and Selling by Quarter

Enanta Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.78  
12/13/2023Terry VanceDirectorSell15,295$9.12$139,490.40  
12/5/2023Brendan LuuVPSell2,125$9.63$20,463.75  
12/5/2023Jay R LulyCEOSell7,230$9.63$69,624.90  
12/5/2023Paul J MellettCFOSell2,412$9.63$23,227.56  
12/5/2023Scott T RottinghausCMOSell534$9.63$5,142.42  
(Data available from 1/1/2013 forward)

ENTA Insider Trading Activity - Frequently Asked Questions

Who is on Enanta Pharmaceuticals's Insider Roster?

The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Bruce L A Carter, Jay R Luly, Nathalie Adda, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA.

What percentage of Enanta Pharmaceuticals stock is owned by insiders?

13.64% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings.

Which Enanta Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($2,671,730.82), Paul J Mellett ($755,876.76), Scott T Rottinghaus ($5,142.42), Tara Lynn Kieffer ($89,589.78), Terry Vance ($139,490.40), and Yat Sun Or ($618,966.25).

How much insider selling is happening at Enanta Pharmaceuticals?

Insiders have sold a total of 122,139 Enanta Pharmaceuticals shares in the last 24 months for a total of $4,301,260.18 sold.

Which members of congress are trading Enanta Pharmaceuticals?

Daniel S. Goldman (D-NY) has sold shares of Enanta Pharmaceuticals in the last year totaling $8,000.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:ENTA) was last updated on 6/21/2024 by Staff

From Our Partners